Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Erg11 mutations associated with azole resistance in clinical isolates of Candida albicans.

Xiang MJ, Liu JY, Ni PH, Wang S, Shi C, Wei B, Ni YX, Ge HL.

FEMS Yeast Res. 2013 Jun;13(4):386-93. doi: 10.1111/1567-1364.12042. Epub 2013 Apr 4.

2.

Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature.

Morio F, Loge C, Besse B, Hennequin C, Le Pape P.

Diagn Microbiol Infect Dis. 2010 Apr;66(4):373-84. doi: 10.1016/j.diagmicrobio.2009.11.006. Review.

PMID:
20226328
3.

Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China.

Liu JY, Shi C, Wang Y, Li WJ, Zhao Y, Xiang MJ.

Res Microbiol. 2015 Apr;166(3):153-61. doi: 10.1016/j.resmic.2015.02.009. Epub 2015 Mar 6.

PMID:
25748216
4.

Relationship between antifungal resistance of fluconazole resistant Candida albicans and mutations in ERG11 gene.

Feng LJ, Wan Z, Wang XH, Li RY, Liu W.

Chin Med J (Engl). 2010 Mar 5;123(5):544-8.

PMID:
20367978
5.

Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China.

Ge SH, Wan Z, Li J, Xu J, Li RY, Bai FY.

Antimicrob Agents Chemother. 2010 Aug;54(8):3126-31. doi: 10.1128/AAC.00118-10. Epub 2010 Jun 1.

6.

Rapid detection of ERG11 gene mutations in clinical Candida albicans isolates with reduced susceptibility to fluconazole by rolling circle amplification and DNA sequencing.

Wang H, Kong F, Sorrell TC, Wang B, McNicholas P, Pantarat N, Ellis D, Xiao M, Widmer F, Chen SC.

BMC Microbiol. 2009 Aug 14;9:167. doi: 10.1186/1471-2180-9-167.

7.

Contribution of clinically derived mutations in ERG11 to azole resistance in Candida albicans.

Flowers SA, Colón B, Whaley SG, Schuler MA, Rogers PD.

Antimicrob Agents Chemother. 2015 Jan;59(1):450-60. doi: 10.1128/AAC.03470-14. Epub 2014 Nov 10.

8.

Nucleotide substitutions in the Candida albicans ERG11 gene of azole-susceptible and azole-resistant clinical isolates.

Strzelczyk JK, Slemp-Migiel A, Rother M, Gołąbek K, Wiczkowski A.

Acta Biochim Pol. 2013;60(4):547-52. Epub 2013 Dec 16.

9.

Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals.

Eddouzi J, Parker JE, Vale-Silva LA, Coste A, Ischer F, Kelly S, Manai M, Sanglard D.

Antimicrob Agents Chemother. 2013 Jul;57(7):3182-93. doi: 10.1128/AAC.00555-13. Epub 2013 Apr 29.

10.

[Azole resistance in Candida spp].

Kakeya H, Miyazaki T, Miyazaki Y, Kohno S.

Nihon Ishinkin Gakkai Zasshi. 2003;44(2):87-92. Review. Japanese.

11.

Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.

Sanglard D, Coste AT.

Antimicrob Agents Chemother. 2015 Oct 19;60(1):229-38. doi: 10.1128/AAC.02157-15.

12.

Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

Marichal P, Koymans L, Willemsens S, Bellens D, Verhasselt P, Luyten W, Borgers M, Ramaekers FC, Odds FC, Bossche HV.

Microbiology. 1999 Oct;145 ( Pt 10):2701-13.

PMID:
10537192
14.

Susceptibility of clinical isolates of Candida species to fluconazole and detection of Candida albicans ERG11 mutations.

Xu Y, Chen L, Li C.

J Antimicrob Chemother. 2008 Apr;61(4):798-804. doi: 10.1093/jac/dkn015. Epub 2008 Jan 24.

PMID:
18218640
15.

In vitro fluconazole susceptibility of 1,903 clinical isolates of Candida albicans and the identification of ERG11 mutations.

Ying Y, Zhao Y, Hu X, Cai Z, Liu X, Jin G, Zhang J, Zhang J, Liu J, Huang X.

Microb Drug Resist. 2013 Aug;19(4):266-73. doi: 10.1089/mdr.2012.0204. Epub 2013 Mar 13.

PMID:
23484590
16.

Selected mechanisms of molecular resistance of Candida albicans to azole drugs.

Gołąbek K, Strzelczyk JK, Owczarek A, Cuber P, Ślemp-Migiel A, Wiczkowski A.

Acta Biochim Pol. 2015;62(2):247-51. doi: 10.18388/abp.2014_940. Epub 2015 Apr 21.

17.

Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.

Mane A, Vidhate P, Kusro C, Waman V, Saxena V, Kulkarni-Kale U, Risbud A.

Mycoses. 2016 Feb;59(2):93-100. doi: 10.1111/myc.12439. Epub 2015 Dec 9.

PMID:
26648048
19.

Genetic analysis of azole resistance in the Darlington strain of Candida albicans.

Kakeya H, Miyazaki Y, Miyazaki H, Nyswaner K, Grimberg B, Bennett JE.

Antimicrob Agents Chemother. 2000 Nov;44(11):2985-90.

20.

ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates.

Xu Y, Sheng F, Zhao J, Chen L, Li C.

Arch Microbiol. 2015 Nov;197(9):1087-93. doi: 10.1007/s00203-015-1146-8. Epub 2015 Sep 8.

PMID:
26349561

Supplemental Content

Support Center